Home/Health & Medicine/Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze

Essay, 1 pages (100 words)

Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze

Subject: Health & Medicine

Info

Published: January 14, 2022
Updated: January 14, 2022
University / College: Queen Mary University of London
Language: English
Downloads: 20

An expression of concern on
Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze

by Roy, K., Cheung, C. H. A., Kanwar, R. K., Sandhir, R., and Kanwar, J. R. (2017). Front. Pharmacol. 8: 223. doi: 10. 3389/fphar. 2017. 00223

With this notice, Frontiers states its awareness of serious allegations surrounding the article “ Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze” published on 5 May 2017. Our Chief Editors will direct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.

UPDATE: This article has now been corrected. Please find the full correction here: https://doi. org/10. 3389/fphar. 2018. 01434

Thank's for Your Vote!

This work, titled "Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze" was written and willingly shared by a fellow student. This sample can be utilized as a research and reference resource to aid in the writing of your own work. Any use of the work that does not include an appropriate citation is banned.

If you are the owner of this work and don’t want it to be published on AssignBuster, request its removal.

Request Removal

Cite this Essay

References

AssignBuster. (2022) 'Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze'. 14 January.

Reference

AssignBuster. (2022, January 14). Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze. Retrieved from https://assignbuster.com/expression-of-concern-topical-ophthalmic-formulation-of-trichostatin-a-and-surr9-c84a-for-quick-recovery-post-alkali-burn-of-corneal-haze/

References

AssignBuster. 2022. "Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze." January 14, 2022. https://assignbuster.com/expression-of-concern-topical-ophthalmic-formulation-of-trichostatin-a-and-surr9-c84a-for-quick-recovery-post-alkali-burn-of-corneal-haze/.

1. AssignBuster. "Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze." January 14, 2022. https://assignbuster.com/expression-of-concern-topical-ophthalmic-formulation-of-trichostatin-a-and-surr9-c84a-for-quick-recovery-post-alkali-burn-of-corneal-haze/.

Bibliography

AssignBuster. "Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze." January 14, 2022. https://assignbuster.com/expression-of-concern-topical-ophthalmic-formulation-of-trichostatin-a-and-surr9-c84a-for-quick-recovery-post-alkali-burn-of-corneal-haze/.

Work Cited

"Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze." AssignBuster, 14 Jan. 2022, assignbuster.com/expression-of-concern-topical-ophthalmic-formulation-of-trichostatin-a-and-surr9-c84a-for-quick-recovery-post-alkali-burn-of-corneal-haze/.

Get in Touch

Please, let us know if you have any ideas on improving Expression of concern: topical ophthalmic formulation of trichostatin a and surr9-c84a for quick recovery post-alkali burn of corneal haze, or our service. We will be happy to hear what you think: [email protected]